Vikas Dharnidharka, M.D., M.P.H.

Profile picture
Director, Division of Pediatric Nephrology, Hypertension and Pheresis
Professor of Pediatrics, Nephrology


Clinical Interests

I provide highly specialized care to children and young adults with all types of kidney disease, with a specific focus on end-stage renal disease and kidney transplantation. I am frequently consulted by colleagues throughout the world to advise with difficult complications of solid organ transplantation. I run a half-day outpatient pediatric nephrology clinic per week, mostly devoted to kidney transplant patients, but I also see patients sent for consultation by other pediatricians as well as patients previously under my care. When in charge of the pediatric nephrology inpatient service, I provide care to children with kidney problems admitted under my charge, consultative service to the other pediatric patients for kidney-related problems, and to the outpatient chronic hemodialysis and peritoneal dialysis patients at St. Louis Children’s Hospital. I perform kidney biopsies and acute hemodialysis or peritoneal dialysis in patients needing these specialized procedures. I also perform plasmapheresis and cellular apheresis for children with renal or non-renal diseases at St. Louis Children’s Hospital. As part of clinical care quality assurance and continuous quality improvement, I review on a very regular basis the quality measures related to procedures (biopsy complication rates), chronic dialysis (vascular access rates, anemia management, bone mineral management, immunization rates) and transplantation (patient and organ graft survival, immunization rates). My research interests are focused on organ transplantation and end stage renal disease. I lead a multi-disciplinary team that investigates the epidemiology of over-immunosuppression complications in transplantation using large national database linkages (NIH grant R01DK102981, PI: Dharnidharka). I lead a separate multi-disciplinary investigating the microbial metagenomic patterns in stored paraffin tissue blocks of post-transplant lymphoproliferative disorders (NIH grant R01AI142135, PI: Dharnidharka). I also investigate biomarkers of acute and chronic rejection and opportunistic infection in translational studies. I am part of a consortium performing a randomized trial to improve adherence in teenagers with a kidney transplant and in consortia that study acute kidney injury (NIH grant R01 DK110737, PI: Foster). I am the site investigator for the NIH-funded CKiD and CureGN studies.


  • MD, Topiwala National Medical College, Bombay University1991
  • MPH, University of Florida College of Public Health2007
  • MBBS, Topiwala National Medical College, (Affiliated with Bombay University)1988


  • Internship, Topiwala National Medical College & Bombay University1987 - 1988
  • Diploma in Child Health (DCH), College of Physicians and Surgeons1988 - 1990
  • Pediatrics Residency, BYL Nair Hospital & Topiwala National Medical College1988 - 1991
  • Pediatrics Residency, Children's Hospital of Michigan & Wayne State University1993 - 1995
  • Pediatric Nephrology Fellowship, Children's Hospital and Harvard Medical School1995 - 1998
  • Advanced Post Graduate Program in Clinical Investigation (APPCI), University of Florida2005 - 2007

Licensure and Board Certification

  • 1988Maharashtra State Medical Council, India
  • 1991Diplomate, National Board of Examinations in Pediatrics, New Delhi, India
  • 1993 - 1995State of Michigan
  • 1993 - 1999NALS/Neonatal Advanced Life Support, American Heart Association
  • 1993 - 2003PALS/Pediatric Advanced Life Support , American Heart Association
  • 1995 - 2002Diplomate; American Board of Pediatric, Chapel Hill, NC
  • 1995 - 2003Board of Registration, Commonwealth of Massachusetts
  • 1999 - 2006Diplomate, Sub-Board in Pediatric Nephrology, American Board of Pediatrics, Chapel Hill, NC
  • 1999 - 2013FL, Board of Medicine, State of Florida
  • 2003 - 2009General Pediatrics, American Board of Pediatrics, Chapel Hill, NC
  • 2005Graduate Record Examination, Educational Testing Service
  • 2006 - 2016Recertification, Pediatric Nephrology
  • 2012 - PresMissouri Board of Registration for the Healing Arts
  • 2014 - PresState of Illinois
  • 2016 - PresRecertification, Pediatric Nephrology

Honors and Awards

  • National Talent Search Scholarship, National Council of Educational Research and Training, Government of India, New Delhi, Inda1980 - 1990
  • Jane Patrao Award (Bronze Medal), 3rd among college class of 100 in entrance examination to T N Medical College, Bombay, India1982
  • H A Maniar Prize (Gold Metal), First among college class of 1991 in Forensic medicine at the 2nd MBBS University examination, Bombay, India1985
  • Bombay University Merit Scholarship, Bombay, India1988 - 1991
  • Best Resident Award, BYL Nair Hospital, Bombay, India1990 - 1991
  • Dr. V B Raju Young Investigators Award, Indian Academy of Pediatrics1992
  • 1st Prize for Best Abstract, Resident Abstract Competition, Michigan Association of Physicians from India1993
  • Hargobind Medical Fellowship Award, Hargobind Foundation, Bombay, India1993
  • Rameshwar Das Birla Fellowship Award, Bombay Hospital Institute Medical Trust, Bombay, India1993
  • The Resident Award for Outstanding Scientific Research, National Convention of the American Association of Physicians from India1994
  • Sheldon Brenner Award for Best Resident Research , Children's Hospital of Michigan1995
  • Physician Recognition Award, American Medical Association1996
  • ASTP Young Investigator Award, American Society of Transplant Physicians1998
  • AST Young Investigator Award, American Society of Transplantation1999
  • Young Investigator Award, International Pediatric Transplant Association2000
  • AAI Junior Faculty Award, American Association of Immunologists2001
  • Physician Recognition Award, American Medical Association2001
  • Society for Pediatric Research, Election to Membership2002
  • ASN Young Investigator Award, American Society of Nephrology2003
  • Physician Recognition Award, American Medical Association2004
  • Junior Faculty Travel Award, 32nd Pediatric Nephrology Seminar Series2005
  • Vice-President's APPCI Fellowship Award, University of Florida2005
  • AST-Wyeth Achievement Award for Assistant Professors in Clinical Science, American Society of Transplantation2006
  • Travel Grant, American Society of Nephrology2006
  • Vocational Service Award, Rotary Club of Bombay Peninsula2006
  • Young Investigator Award, North American Pediatric Transplant Cooperative Study2006
  • Expert Faculty Resource Service, American Society of Transplantation2006 - 2007
  • Young Investigator Award, 5th Immunology of Diabetes International Congress2007
  • Best Doctors in America2007 - 2008
  • Faculty Enhancement Opportunity Award, University of Florida2008
  • Certificate of Recognition, Outstanding Achievement in Pediatric Medical Student Education2008 - 2009
  • Best Doctors in America2009 - 2010
  • Inducted into Delta Omega, Honorary Alumni Society in Public Health, University of Florida's College of Public Health and Health Professions' Beta Epsilon Chapter2010
  • Best Doctors in America2011 - 2012
  • AST Investigator Achievement Award Clinical Science, American Society of Transplantation2012
  • Best Doctors in America2013 - 2014
  • Best Doctors in America2015 - 2016
  • Best Doctors in America2016 - 2017
  • Nominated for Board of Directors election slate, American Society of Transplantation2017
  • Best Doctors in America2017 - 2018
  • Elected Chair, Section of Nephrology, American Academy of Pediatrics2018 - 2020
  • Election to National Governing Council, American Society of Pediatric Nephrology2020 - 2024
  • Re-elected to second 2-year term as Chair, Section of Nephrology, American Academy of Pediatrics2020 - 2022
  • Selected as one of five national Scholars, Pediatric Leadership Development Course, American Medical School Pediatric Department Chairs Association of2021 - 2022

Recent Publications view all (225)

  1. Impact of CYP3A5 Status on the Clinical and Financial Outcomes Among African American Kidney Transplant Recipients. Transplant Direct. 2022;8(10):e1379. PMCID:PMC9529042  PMID:36204191 
  2. Skeletal Outcomes in Children and Young Adults with Glomerular Disease. J Am Soc Nephrol. 2022. PMID:36171052 
  3. Simultaneous pediatric heart-kidney transplant outcomes in the US: A-25 year National Cohort Study. Pediatr Transplant. 2022;26(1):e14149. PMID:34585490 
  4. Mean lifetime survival estimates following solid organ transplantation in the US and UK. J Med Econ. 2022;25(1):230-237. PMID:35068310 
  5. Using a Multi-Institutional Pediatric Learning Health System to Identify Systemic Lupus Erythematosus and Lupus Nephritis: Development and Validation of Computable Phenotypes. Clin J Am Soc Nephrol. 2022;17(1):65-74. PMCID:PMC8763148  PMID:34732529 
  6. Successful treatment of CNS involvement in a patient with widely disseminated PTLD through the addition of intrathecal methotrexate to standard therapy. Pediatr Blood Cancer. 2021;68(11):e29236. PMID:34260152 
  7. Donor-derived ehrlichiosis: two clusters following solid organ transplantation. Clin Infect Dis. 2021. PMID:34329411 
  8. Cumulative Application of Creatinine and Urine Output Staging Optimizes the Kidney Disease: Improving Global Outcomes Definition and Identifies Increased Mortality Risk in Hospitalized Patients With Acute Kidney Injury. Crit Care Med. 2021. PMID:33938717 
  9. Performance of the various serum creatinine-based GFR estimating equations in pediatric kidney transplant recipients, stratified by age and CKD staging. Pediatr Nephrol. 2021. PMID:33893542 
  10. Low-Dose Antithymocyte Globulin Has No Disadvantages to Standard Higher Dose in Pediatric Kidney Transplant Recipients: Report From the Pediatric Nephrology Research Consortium. Kidney Int Rep. 2021;6(4):995-1002. PMCID:PMC8071617  PMID:33912749 
  11. Risk of antibiotic treatment failure in premenopausal women with uncomplicated urinary tract infection. Pharmacoepidemiol Drug Saf. 2021. PMID:33783918 
  12. Cost burden of post-transplant lymphoproliferative disease following kidney transplants in Medicare-eligible patients by survival status. J Med Econ. 2021;24(1):620-627. PMID:33851571 
  13. Late first acute rejection in pediatric kidney transplantation: A North American Pediatric Renal Trials and Collaborative Studies special study. Pediatr Transplant. 2020;e13953. PMID:33350558 
  14. Thrombotic Microangiopathy Following Onasemnogene Abeparvovec for Spinal Muscular Atrophy: A Case Series. J Pediatr. 2020. PMID:33259859 
  15. Post-transplant malignancies in pediatric organ transplant recipients. Pediatr Transplant. 2020;e13884. PMID:33111463 
  16. Acute Kidney Injury in Children: Being AWARE. Pediatrics. 2020;146(3). PMID:32784226 
  17. Reassessing Rabbit Antithymocyte Globulin Induction in Kidney Transplantation (RETHINK): An Analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Registry. Transplant Direct. 2020;6(9):e598. PMCID:PMC7447457  PMID:32903852 
  18. The progression of serum cystatin C concentrations within the first month of life after preterm birth-a worldwide systematic review. Pediatr Nephrol. 2020. PMID:32757062 
  19. Weight as a Risk Factor for Mortality in Critically Ill Patients. Pediatrics. 2020;146(2). PMCID:PMC7397732  PMID:32620676 
  20. Comparative safety of high-dose versus standard-dose influenza vaccination in patients with end-stage renal disease. Vaccine. 2020;38(33):5178-5186. PMCID:PMC7332402  PMID:32565346 
  21. Outcome implications of benzodiazepine and opioid co-prescription in kidney transplant recipients. Clin Transplant. 2020;e14005. PMID:32510628 
  22. In Reply to 'High-Dose Versus Standard-Dose Influenza Vaccine in Hemodialysis Patients'. Am J Kidney Dis. 2020;75(3):456-457. PMID:31980252 
  23. Impacts of center and clinical factors in antihypertensive medication use after kidney transplantation. Clin Transplant. 2020;34(3):e13803. PMID:31997429 
  24. Economic impacts of alternative kidney transplant immunosuppression: A national cohort study. Clin Transplant. 2020;e13813. PMID:32027049 
  25. Using Electronic Health Record Data to Rapidly Identify Children with Glomerular Disease for Clinical Research. J Am Soc Nephrol. 2019;30(12):2427-2435. PMCID:PMC6900784  PMID:31732612 
  26. Kidney transplant practice patterns and outcome benchmarks over 30 years: The 2018 report of the NAPRTCS. Pediatr Transplant. 2019;e13597. PMID:31657095 
  27. Association between day of the week and medication adherence among adolescent and young adult kidney transplant recipients. Am J Transplant. 2019. PMID:31507087 
  28. Using Electronic Health Record Data to Rapidly Identify Children with Glomerular Disease for Clinical Research J Am Soc Nephrol. 2019. 
  29. Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccine Among Patients Receiving Maintenance Hemodialysis. Am J Kidney Dis. 2019. PMID:31378646 
  30. Scientometrics: Judging the impact of published articles in the field of pediatric kidney transplantation. Pediatr Transplant. 2019;23(5):e13533. PMID:31364235 
  31. Perceived barriers to medication adherence remain stable following solid organ transplantation. Pediatr Transplant. 2019;23(3):e13361. PMCID:PMC6652201  PMID:31332928 
  32. Phase I study of single-dose pharmacokinetics and pharmacodynamics of belatacept in adolescent kidney transplant recipients. Am J Transplant. 2019;19(4):1218-1223. PMCID:PMC6590112  PMID:30582294 
  33. Oliguria and Acute Kidney Injury in Critically Ill Children: Implications for Diagnosis and Outcomes. Pediatr Crit Care Med. 2019;20(4):332-339. PMID:30676490 
  34. A Recipient Risk Prediction Tool for Short Term Mortality after Pediatric Heart Transplantation. Transplantation. 2019. PMID:30801538 
  35. Cannabis Dependence or Abuse in Kidney Transplantation: Implications for Posttransplant Outcomes. Transplantation. 2019. PMID:30747847 
  36. A social media editor for pediatric transplantation. Pediatr Transplant. 2019;23(1):e13343. PMID:30635957 
  37. Metagenomic analysis of DNA viruses from posttransplant lymphoproliferative disorders. Cancer Med. 2019. PMID:30697958 
  38. Clinical phenotypes and biologic treatment use in juvenile dermatomyositis-associated calcinosis. Pediatr Rheumatol Online J. 2018;16(1):84. PMCID:PMC6311016  PMID:30594206 
  39. Renal transplantation and predisposition to opportunistic infections. Curr Opin Pediatr. 2018. PMID:30562175 
  40. Using the newer Kidney Disease: Improving Global Outcomes criteria, beta-2-microglobulin levels associate with severity of acute kidney injury. Clin Kidney J. 2018;11(6):797-802. doi:10.1093/ckj/sfy056  PMID:30524714 
  41. Gender differences in medication adherence among adolescent and young adult kidney transplant recipients. Transplantation. 2018. PMID:29994983 
  42. Center-driven and Clinically Driven Variation in US Liver Transplant Maintenance Immunosuppression Therapy: A National Practice Patterns Analysis. Transplant Direct. 2018;4(7):e364. PMCID:PMC6056277  PMID:30046654 
  43. Metformin use in the first year after kidney transplant, correlates, and associated outcomes in diabetic transplant recipients: A retrospective analysis of integrated registry and pharmacy claims data. Clin Transplant. 2018;e13302. PMID:29851159 
  44. The impact of direct-acting antiviral agents on liver and kidney transplant costs and outcomes. Am J Transplant. 2018. PMID:29701909 
  45. A Randomized Trial of a Multicomponent Intervention to Promote Medication Adherence: The Teen Adherence in Kidney Transplant Effectiveness of Intervention Trial (TAKE-IT). Am J Kidney Dis. 2018. PMID:29602631 
  46. Prescription Opioid Use Before and After Kidney Transplant: Implications for Post-transplant Outcomes. Am J Transplant. 2018. PMID:29498196 
  47. Non-immunologic allograft loss in pediatric kidney transplant recipients. Pediatr Nephrol. 2018. PMID:29480356 
  48. Assessment of a renal angina index for prediction of severe acute kidney injury in critically ill children: a multicentre, multinational, prospective observational study. Lancet Child Adolesc Health. 2018;2(2):112-120. PMID:30035208 
  49. The utility of surveillance biopsies in pediatric kidney transplantation. Pediatr Nephrol. 2017. PMID:29260318 
  50. Comprehensive Review of Post-Organ Transplant Hematologic Cancers. Am J Transplant. 2017. PMID:29178667 
  51. Type 3 renal tubular acidosis associated with growth hormone deficiency. J Pediatr Endocrinol Metab. 2017;30(10):1047-1053. PMID:28888090 
  52. Center practice drives variation in choice of US kidney transplant induction therapy: a retrospective analysis of contemporary practice. Transpl Int. 2017. PMID:28987015 
  53. End-stage renal disease after pediatric heart transplantation: A 25-year national cohort study. J Heart Lung Transplant. 2017. PMID:29055603 
  54. Assessment, classification and treatment of calcinosis as a complication of juvenile dermatomyositis: a survey of pediatric rheumatologists by the childhood arthritis and rheumatology research alliance (CARRA). Pediatr Rheumatol Online J. 2017;15(1):71. PMCID:PMC5609060  PMID:28934971 
  55. Antidepressant medication use before and after kidney transplant: implications for outcomes - A retrospective study. Transpl Int. 2017. PMID:28771882 
  56. Biomarkers to detect rejection after kidney transplantation. Pediatr Nephrol. 2017. PMID:28631040 
  57. Mutations in sphingosine-1-phosphase lyase cause nephrosis with ichthyosis and adrenal insufficiency. J Clin Invest. 2017. PMID:28165339 
  58. Ureteral stent placement and immediate graft function are associated with increased risk of BK viremia in the first year after kidney transplantation. Transpl Int. 2017;30(2):153-161. PMID:27862417 
  59. Epidemiology of Acute Kidney Injury in Critically Ill Children and Young Adults. N Engl J Med. 2017;376(1):11-20. PMID:27959707 
  60. The Changing Financial Landscape of Renal Transplant Practice: A National Cohort Analysis. Am J Transplant. 2016. PMID:27565133 
  61. Differential Risks for Adverse Outcomes 3-Years after Kidney Transplantation Based on Initial Immunosuppression Regimen: A National Study. Transpl Int. 2016. PMID:27564782 
  62. Effects of Obesity and Hypertension on Pulse Wave Velocity in Children. J Clin Hypertens (Greenwich). 2016. PMID:27511880 
  63. Clinical and Economic Consequences of Early Cancer after Kidney Transplantation in Contemporary Practice. Transplantation. 2016. PMID:27490413 
  64. Peripheral blood Epstein-Barr viral nucleic acid surveillance as a marker for post-transplant cancer risk. Am J Transplant. 2016. doi:10.1111/ajt.13982  PMID:27458691 
  65. Pretransplant Midodrine Use: A Newly Identified Risk Marker for Complications After Kidney Transplantation. Transplantation. 2016. doi:10.1097/TP.0000000000001113  PMID:26950718 
  66. National variation in use of Immunosuppression for kidney transplantation: A call for evidence-based regimen selection. Am J Transplant. 2016. doi:10.1111/ajt.13758  PMID:26901466 
  67. Post-transplant lymphoproliferative disorders. Nat Rev Dis Primers. 2016;2:15088. doi:10.1038/nrdp.2015.88  PMID:27189056 
  68. Variation in Comedication Use According to Kidney Transplant Immunosuppressive Regimens: Application of Integrated Registry and Pharmacy Claims Data. Transplant Proc. 2016;48(1):55-8. doi:10.1016/j.transproceed.2015.12.024  PMID:26915843 
  69. Perceived barriers to medication adherence in pediatric and adolescent solid organ transplantation. Pediatr Transplant. 2015. doi:10.1111/petr.12648  PMID:26670870 
  70. Economic Impacts of ABO-Incompatible Live Donor Kidney Transplantation: A National Study of Medicare-Insured Recipients. Am J Transplant. 2015. doi:10.1111/ajt.13616  PMID:26603690 
  71. High Risk of Liver Allograft Failure During Late Adolescence and Young Adulthood. Transplantation. 2015. doi:10.1097/TP.0000000000001009  PMID:26588009 
  72. Clinical and economic consequences of first-year urinary tract infections, sepsis, and pneumonia in contemporary kidney transplantation practice. Transpl Int. 2015. doi:10.1111/tri.12711  PMID:26563524 
  73. Sexually transmitted infection screening and reproductive health counseling in adolescent renal transplant recipients: Perceptions and practice patterns. A study from the Midwest Pediatric Nephrology Consortium. Pediatr Transplant. 2015. doi:10.1111/petr.12579  PMID:26260626 
  74. De novo development of antibodies to kidney-associated self-antigens angiotensin II receptor type I, collagen IV, and fibronectin occurs at early time points after kidney transplantation in children. Pediatr Transplant. 2015;19(5):499-503. doi:10.1111/petr.12531  PMCID:PMC4485575  PMID:26058970 
  75. Lack of significant improvements in long-term allograft survival in pediatric solid organ transplantation: A US national registry analysis. Pediatr Transplant. 2015;19(5):477-83. doi:10.1111/petr.12465  PMID:25832769 
  76. Across all solid organs, adolescent age recipients have worse transplant organ survival than younger age children: A US national registry analysis. Pediatr Transplant. 2015;19(5):471-6. doi:10.1111/petr.12464  PMID:25832588 
  77. High Risk of Graft Failure in Emerging Adult Heart Transplant Recipients. Am J Transplant. 2015. doi:10.1111/ajt.13386  PMID:26189336 
  78. Kidney transplant results in children: progress made, but blacks lag behind. Kidney Int. 2015;87(3):492-4. PMCID:PMC4378232  PMID:25723630 
  79. Assessment of Worldwide Acute Kidney Injury, Renal Angina and Epidemiology in critically ill children (AWARE): study protocol for a prospective observational study. BMC Nephrol. 2015;16:24. doi:10.1186/s12882-015-0016-6  PMCID:PMC4355130  PMID:25882434 
  80. New approaches to treating B-cell cancers induced by Epstein-Barr virus. N Engl J Med. 2015;372(6):569-71. doi:10.1056/NEJMcibr1415117  PMID:25651254 
  81. Quantifying prognostic impact of prescription opioid use before kidney transplantation through linked registry and pharmaceutical claims data. Transplantation. 2015;99(1):187-96. doi:10.1097/TP.0000000000000248  PMID:25531895 
  82. Associations of pre-transplant prescription narcotic use with clinical complications after kidney transplantation. Am J Nephrol. 2015;41(2):165-76. doi:10.1159/000377685  PMID:25832723 
  83. The TAKE-IT study: aims, design, and methods. BMC Nephrol. 2014;15:139. doi:10.1186/1471-2369-15-139  PMCID:PMC4236658  PMID:25176317 
  84. Viral surveillance and subclinical viral infection in pediatric kidney transplantation. Pediatr Nephrol. 2014. doi:10.1007/s00467-014-2866-8  PMID:25125226 
  85. Kidney transplantation in children. N Engl J Med. 2014;371(6):549-58. doi:10.1056/NEJMra1314376  PMID:25099579 
  86. The ImmuKnow assay--does it really put us in the know about the immune system? Pediatr Transplant. 2014;18(5):415-6. PMID:25041327 
  87. Early clinical complications after ABO-incompatible live-donor kidney transplantation: a national study of Medicare-insured recipients. Transplantation. 2014;98(1):54-65. doi:10.1097/TP.0000000000000029  PMCID:PMC4411309  PMID:24978035 
  88. Bartonella henselae infection inducing hemophagocytic lymphohistiocytosis in a kidney transplant recipient. Pediatr Transplant. 2014;18(3):E83-7. PMID:24829973 
  89. Stable pediatric kidney transplant recipients run higher urine indoleamine 2, 3 dioxygenase (IDO) levels than healthy children. Pediatr Transplant. 2014;18(3):254-7. doi:10.1111/petr.12232  PMCID:PMC3981946  PMID:24483723 
  90. Hypertension in the teenager. Pediatr Clin North Am. 2014;61(1):131-51. doi:10.1016/j.pcl.2013.09.011  PMCID:PMC3947917  PMID:24267462 
  91. Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report. Pediatr Radiol. 2014;44(2):173-80. doi:10.1007/s00247-013-2795-x  PMCID:PMC3946726  PMID:24057195 
  92. Efficacy of Extended Valganciclovir Prophylaxis in Preventing Cytomegalovirus Infection in Pediatric Kidney Transplantation. Open Urol Nephrol J. 2014;7(Suppl 2 M7):152-157. doi:10.2174/1874303X01407010152  PMID:25821528 
  93. Ureteral Stent Placement Increases the Risk for Developing BK Viremia after Kidney Transplantation. J Transplant. 2014;2014:459747. doi:10.1155/2014/459747  PMCID:PMC4177822  PMID:25295178 
  94. Non-post-transplant lymphoproliferative disorder cancers in children after organ transplantation. Pediatr Transplant. 2013;17(8):707-9. PMID:24118973 
  95. Urinary-cell mRNA and acute kidney-transplant rejection. N Engl J Med. 2013;369(19):1858-9. doi:10.1056/NEJMc1310006#SA2  PMID:24195556 
  96. Verification of association of elevated serum IDO enzyme activity with acute rejection and low CD4-ATP levels with infection. Transplantation. 2013;96(6):567-72. doi:10.1097/TP.0b013e31829c7cec  PMCID:PMC3875171  PMID:23823655 
  97. Management of anemia in children receiving chronic peritoneal dialysis. J Am Soc Nephrol. 2013;24(4):665-76. doi:10.1681/ASN.2012050433  PMCID:PMC3609132  PMID:23471197 
  98. Best allograft survival from share-35 kidney donors occurs in middle-aged adults and young children-an analysis of OPTN data. Transplantation. 2013;95(2):319-25. doi:10.1097/TP.0b013e3182719203  PMID:23154211 
  99. Understanding medical care of transplant recipients through integrated registry and pharmacy claims data. Am J Nephrol. 2013;38(5):420-9. doi:10.1159/000356092  PMID:24216747 
  100. The Seville expert workshop for progress in posttransplant lymphoproliferative disorders. Transplantation. 2012;94(8):784-93. doi:10.1097/TP.0b013e318269e64f  PMID:22992767 
  101. Subclinical inflammation and chronic renal allograft injury in a randomized trial on steroid avoidance in pediatric kidney transplantation. Am J Transplant. 2012;12(10):2730-43. doi:10.1111/j.1600-6143.2012.04144.x  PMCID:PMC3459071  PMID:22694733 
  102. Complete steroid avoidance is effective and safe in children with renal transplants: a multicenter randomized trial with three-year follow-up. Am J Transplant. 2012;12(10):2719-29. doi:10.1111/j.1600-6143.2012.04145.x  PMID:22694755 
  103. A peripheral blood diagnostic test for acute rejection in renal transplantation. Am J Transplant. 2012;12(10):2710-8. doi:10.1111/j.1600-6143.2012.04253.x  PMID:23009139 
  104. Missed viral surveillance testing visits associate with full blown viral diseases in children receiving kidney transplants. Pediatr Transplant. 2012. doi:10.1111/j.1399-3046.2012.01773.x  PMID:22905915 
  105. Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C. Kidney Int. 2012;82(4):445-53. doi:10.1038/ki.2012.169  PMCID:PMC3433576  PMID:22622496 
  106. Less invasive biomarkers of acute rejection: reaching the elusive clinic. Pediatr Transplant. 2012;16(4):308-9. doi:10.1111/j.1399-3046.2012.01679.x  PMID:22489748 
  107. Associations between EBV serostatus and organ transplant type in PTLD risk: an analysis of the SRTR National Registry Data in the United States. Am J Transplant. 2012;12(4):976-83. doi:10.1111/j.1600-6143.2011.03893.x  PMID:22226225 
  108. Reliability of resting blood pressure measurement and classification using an oscillometric device in children with chronic kidney disease. J Pediatr. 2012;160(3):434-440.e1. doi:10.1016/j.jpeds.2011.08.071  PMCID:PMC3274610  PMID:22048052 
  109. Comorbidities in chronic pediatric peritoneal dialysis patients: a report of the International Pediatric Peritoneal Dialysis Network. Perit Dial Int. 2012;32(4):410-8. doi:10.3747/pdi.2012.00124  PMCID:PMC3524853  PMID:22859841 
  110. Impact of global economic disparities on practices and outcomes of chronic peritoneal dialysis in children: insights from the International Pediatric Peritoneal Dialysis Network Registry. Perit Dial Int. 2012;32(4):399-409. doi:10.3747/pdi.2012.00126  PMCID:PMC3524840  PMID:22859840 
  111. Growth in very young children undergoing chronic peritoneal dialysis. J Am Soc Nephrol. 2011;22(12):2303-12. doi:10.1681/ASN.2010020192  PMCID:PMC3279935  PMID:22021715 
  112. Lymphoproliferative disorders after adult kidney transplant: epidemiology and comparison of registry report with claims-based diagnoses. Am J Kidney Dis. 2011;58(6):971-80. doi:10.1053/j.ajkd.2011.07.015  PMID:21930332 
  113. The BK virus in renal transplant recipients-review of pathogenesis, diagnosis, and treatment. Pediatr Nephrol. 2011;26(10):1763-74. doi:10.1007/s00467-010-1716-6  PMID:21161285 
  114. Urological disorders in chronic kidney disease in children cohort: clinical characteristics and estimation of glomerular filtration rate. J Urol. 2011;186(4):1460-6. doi:10.1016/j.juro.2011.05.059  PMID:21855938 
  115. Racial variation in the development of posttransplant lymphoproliferative disorders after renal transplantation. Transplantation. 2011;92(2):190-5. doi:10.1097/TP.0b013e3182200e8a  PMID:21577180 
  116. Incidence, predictors and associated outcomes of renal cell carcinoma in long-term dialysis patients. Urology. 2011;77(6):1271-6. doi:10.1016/j.urology.2011.01.007  PMID:21459420 
  117. Posttransplantation lymphoproliferative disorder in kidney and heart transplant recipients receiving thymoglobulin: a systematic review. Transplant Proc. 2011;43(5):1395-404. doi:10.1016/j.transproceed.2011.03.036  PMID:21693205 
  118. Immune biomarker panel monitoring utilizing IDO enzyme activity and CD4 ATP levels: prediction of acute rejection vs. viral replication events. Pediatr Transplant. 2011;15(3):321-8. doi:10.1111/j.1399-3046.2011.01485.x  PMCID:PMC3078420  PMID:21492353 
  119. Improved survival with recent Post-Transplant Lymphoproliferative Disorder (PTLD) in children with kidney transplants. Am J Transplant. 2011;11(4):751-8. doi:10.1111/j.1600-6143.2011.03470.x  PMID:21446977 
  120. The factors that may predict response to rituximab therapy in recurrent focal segmental glomerulosclerosis: a systematic review. J Transplant. 2011;2011:374213. doi:10.1155/2011/374213  PMCID:PMC3235904  PMID:22174985 
  121. The bone and mineral disorder of children undergoing chronic peritoneal dialysis. Kidney Int. 2010;78(12):1295-304. doi:10.1038/ki.2010.316  PMID:20811335 
  122. Comparison of generic tacrolimus and Prograf drug levels in a pediatric kidney transplant program: brief communication. Pediatr Transplant. 2010;14(8):1007-11. doi:10.1111/j.1399-3046.2010.01393.x  PMID:20819180 
  123. Post-transplant lymphoproliferative disorder in children: recent outcomes and response to dual rituximab/low-dose chemotherapy combination. Pediatr Transplant. 2010;14(7):896-902. doi:10.1111/j.1399-3046.2010.01370.x  PMID:20642490 
  124. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis. 2010;10(8):521-6. doi:10.1016/S1473-3099(10)70133-X  PMCID:PMC3045703  PMID:20620116 
  125. Xanthogranulomatous pyelonephritis in pediatric patients: case report and review of literature. J Pediatr Urol. 2010;6(4):355-8. doi:10.1016/j.jpurol.2009.09.014  PMID:19864185 
  126. Retransplantation after BK virus nephropathy in prior kidney transplant: an OPTN database analysis. Am J Transplant. 2010;10(5):1312-5. doi:10.1111/j.1600-6143.2010.03083.x  PMID:20353461 
  127. Leflunomide therapy for BK virus allograft nephropathy in pediatric and young adult kidney transplant recipients. Pediatr Transplant. 2010;14(1):145-50. doi:10.1111/j.1399-3046.2009.01183.x  PMID:19344337 
  128. PTLD treatment: reducing the chemotherapy burden through addition of rituximab. Pediatr Transplant. 2010;14(1):10-1. doi:10.1111/j.1399-3046.2009.01289.x  PMID:20078838 
  129. Viral immune monitoring for post-transplant lymphoproliferative disorder. Pediatr Transplant. 2009;13(5):521-3. doi:10.1111/j.1399-3046.2009.01144.x  PMID:19254268 
  130. Melamine-contaminated powdered formula and urolithiasis. N Engl J Med. 2009;360(25):2676; author reply 2677-8. PMID:19537318 
  131. Native kidney post-transplant lymphoproliferative disorder in a non-renal transplant patient. Pediatr Transplant. 2009;13(4):495-8. doi:10.1111/j.1399-3046.2008.01001.x  PMID:18673359 
  132. An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States. Transplantation. 2009;87(7):1019-26. doi:10.1097/TP.0b013e31819cc383  PMID:19352121 
  133. Post-transplant lymphoproliferative disease. Pediatr Nephrol. 2009;24(4):731-6. doi:10.1007/s00467-007-0582-3  PMID:17891420 
  134. Validation of creatinine assays utilizing HPLC and IDMS traceable standards in sera of children. Pediatr Nephrol. 2009;24(1):113-9. doi:10.1007/s00467-008-0957-0  PMCID:PMC2788619  PMID:18769945 
  135. Uric acid--a bad acid for the kidney? Pediatr Transplant. 2008;12(8):821-2. doi:10.1111/j.1399-3046.2008.00986.x  PMID:18503480 
  136. Low viral load post-transplant lymphoproliferative disease localized within the tongue. Transpl Infect Dis. 2008;10(6):426-30. doi:10.1111/j.1399-3062.2008.00328.x  PMID:18657087 
  137. Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation. Transplantation. 2008;86(10):1474-8. doi:10.1097/TP.0b013e31818b62c8  PMID:19034021 
  138. Adolescent Transition to Adult Care in Solid Organ Transplantation: a consensus conference report. Am J Transplant. 2008;8(11):2230-42. doi:10.1111/j.1600-6143.2008.02415.x  PMID:18822088 
  139. Intermediate dose cidofovir does not cause additive nephrotoxicity in BK virus allograft nephropathy. Pediatr Transplant. 2008;12(7):790-5. doi:10.1111/j.1399-3046.2008.00937.x  PMID:18537898 
  140. Recombinant growth hormone use pretransplant and risk for post-transplant lymphoproliferative disease--a report of the NAPRTCS. Pediatr Transplant. 2008;12(6):689-95. doi:10.1111/j.1399-3046.2007.00881.x  PMID:18179637 
  141. Assessing the value of ureteral stent placement in pediatric kidney transplant recipients. Transplantation. 2008;85(7):986-91. doi:10.1097/TP.0b013e318169bf11  PMID:18408579 
  142. Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab. Am J Transplant. 2007;7(11):2619-25. doi:10.1111/j.1600-6143.2007.01972.x  PMCID:PMC2778321  PMID:17868060 
  143. Gadolinium and nephrogenic fibrosing dermopathy in pediatric patients. Pediatr Nephrol. 2007;22(9):1395. doi:10.1007/s00467-006-0384-z  PMID:17180360 
  144. BK virus nephropathy in pediatric renal transplant recipients: an analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry. Clin J Am Soc Nephrol. 2007;2(5):1037-42. doi:10.2215/CJN.04051206  PMID:17702713 
  145. Hemodialysis catheter-related bacteremia in children: increasing antibiotic resistance and changing bacteriological profile. Am J Kidney Dis. 2007;50(1):119-23. doi:10.1053/j.ajkd.2007.04.005  PMID:17591531 
  146. Risk factors for hospitalization for bacterial or viral infection in renal transplant recipients--an analysis of USRDS data. Am J Transplant. 2007;7(3):653-61. doi:10.1111/j.1600-6143.2006.01674.x  PMID:17250559 
  147. Younger age and antibody induction increase the risk for infection in pediatric renal transplantation: a NAPRTCS report. Am J Transplant. 2007;7(3):662-6. doi:10.1111/j.1600-6143.2006.01675.x  PMID:17250558 
  148. Effects of urinary tract infection on outcomes after renal transplantation in children. Clin J Am Soc Nephrol. 2007;2(1):100-6. doi:10.2215/CJN.01820506  PMID:17699393 
  149. Sodium thiosulfate treatment for calcific uremic arteriolopathy in children and young adults. Clin J Am Soc Nephrol. 2006;1(6):1161-6. doi:10.2215/CJN.01520506  PMID:17699342 
  150. Rapid growth of a kidney angiomyolipoma after initiation of oral contraceptive therapy. Obstet Gynecol. 2006;108(3 Pt 2):734-6. doi:10.1097/01.AOG.0000188062.13749.ef  PMID:17018483 
  151. Infection frequency and profile in different age groups of kidney transplant recipients. Transplantation. 2006;81(12):1662-7. doi:10.1097/  PMID:16794532 
  152. Systemic Epstein-Barr virus infection associated with membranous nephropathy in children. Clin Nephrol. 2006;65(3):160-4. PMID:16550746 
  153. Infected kidney cysts. Kidney Int. 2006;69(5):783. doi:10.1038/  PMID:16518337 
  154. Acute-onset hearing loss with renal failure: differential diagnosis. Am J Kidney Dis. 2006;47(3):553-8. doi:10.1053/j.ajkd.2005.11.028  PMID:16490636 
  155. Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy. Pediatr Transplant. 2006;10(1):32-7. doi:10.1111/j.1399-3046.2005.00391.x  PMID:16499584 
  156. Post-transplant lymphoproliferative disease: association with induction therapy? Drugs. 2006;66(4):429-38. PMID:16597161 
  157. New-onset gout after kidney transplantation: incidence, risk factors and implications. Transplantation. 2005;80(10):1383-91. PMID:16340779 
  158. Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation. 2005;80(9):1233-43. PMID:16314791 
  159. Costimulation blockade with belatacept in renal transplantation. N Engl J Med. 2005;353(19):2085-6; author reply 2085-6. doi:10.1056/NEJM200511103531919  PMID:16282187 
  160. Risk for post-transplant lymphoproliferative disorder after polyclonal antibody induction in kidney transplantation. Pediatr Transplant. 2005;9(5):622-6. doi:10.1111/j.1399-3046.2005.00361.x  PMID:16176420 
  161. Utility of renal imaging in the diagnostic evaluation of obese childhood primary hypertension. Clin Pediatr (Phila). 2005;44(7):589-92. PMID:16151564 
  162. Renal transplantation: the present and the future. Indian J Pediatr. 2005;72(9):785-8. PMID:16186682 
  163. Sirolimus in pediatric solid organ transplantation. Pediatr Transplant. 2005;9(4):427-9. doi:10.1111/j.1399-3046.2005.00385.x  PMID:16048592 
  164. Isolated idiopathic hypomagnesemia presenting as aphasia and seizures. Pediatr Neurol. 2005;33(1):61-5. doi:10.1016/j.pediatrneurol.2005.02.005  PMID:15876516 
  165. En-bloc kidney transplantation in the United states: an analysis of united network of organ sharing (UNOS) data from 1987 to 2003. Am J Transplant. 2005;5(6):1513-7. doi:10.1111/j.1600-6143.2005.00878.x  PMID:15888062 
  166. Hodgkin's-like PTLD versus true Hodgkin's disease. Pediatr Transplant. 2004;8(6):581-2. doi:10.1111/j.1399-3046.2004.00225.x  PMID:15598328 
  167. TNP-470, an angiogenesis inhibitor, attenuates the development of allograft vasculopathy. Transplantation. 2004;78(8):1218-21. PMID:15502723 
  168. Nephrogenic fibrosing dermopathy in pediatric patients. Pediatr Nephrol. 2004;19(4):467-70. doi:10.1007/s00467-003-1380-1  PMID:14872332 
  169. Post-transplant infections now exceed acute rejection as cause for hospitalization: a report of the NAPRTCS. Am J Transplant. 2004;4(3):384-9. PMID:14961991 
  170. Hodgkin's lymphoma after post-transplant lymphoproliferative disease in a renal transplant recipient. Pediatr Transplant. 2004;8(1):87-90. doi:10.1046/j.1397-3142.2003.00113.x  PMID:15009846 
  171. Dual monoclonal antibody therapy for the treatment of PTLD? Pediatr Transplant. 2003;7(5):337-8. PMID:14738290 
  172. Transient proximal tubular renal injury following Ecstasy ingestion. Pediatr Nephrol. 2003;18(8):820-2. doi:10.1007/s00467-003-1164-7  PMID:12774221 
  173. Post-transplant lymphoproliferative disorder in the United States: young Caucasian males are at highest risk. Am J Transplant. 2002;2(10):993-8. PMID:12482154 
  174. Mycophenolate, tacrolimus and post-transplant lymphoproliferative disorder: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant. 2002;6(5):396-9. PMID:12390426 
  175. Prolonged neuromuscular block due to cholinesterase depletion by plasmapheresis. J Clin Anesth. 2002;14(5):381-4. PMID:12208445 
  176. Cat scratch disease and acute rejection after pediatric renal transplantation. Pediatr Transplant. 2002;6(4):327-31. PMID:12234274 
  177. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis. 2002;40(2):221-6. doi:10.1053/ajkd.2002.34487  PMID:12148093 
  178. Extracorporeal removal of toxic valproic acid levels in children. Pediatr Nephrol. 2002;17(5):312-5. doi:10.1007/s00467-002-0841-2  PMID:12042885 
  179. Fas stimulation results in selective islet infiltrate apoptosis in situ and reversal of diabetes. Ann N Y Acad Sci. 2002;958:160-2. PMID:12021097 
  180. Management of pediatric postrenal transplantation infections. Semin Nephrol. 2001;21(5):521-31. PMID:11559893 
  181. Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation. 2001;71(8):1065-8. PMID:11374404 
  182. Pulmonary dysplasia, Denys-Drash syndrome and Wilms tumor 1 gene mutation in twins. Pediatr Nephrol. 2001;16(3):227-31. PMID:11322369 
  183. Reduced susceptibility of nonobese diabetic mice to TNF-alpha and D-galactosamine-mediated hepatocellular apoptosis and lethality. J Immunol. 2000;165(11):6559-67. PMID:11086099 
  184. Primary nocturnal enuresis--where do we stand today? Indian Pediatr. 2000;37(2):135-40. PMID:10745407 
  185. Failure of combined costimulatory blockade in animal transplant model. Nat Med. 2000;6(2):115. doi:10.1038/72166  PMID:10655074 
  186. Urinary tract infection guidelines questioned. Pediatrics. 2000;105(2):465-6; author reply 466-7. PMID:10691520 
  187. Angiogenesis in the huPBL-SCID model of human transplant rejection. Transplantation. 1999;67(12):1626-31. PMID:10401773 
  188. The allogeneic response to cultured human skin equivalent in the hu-PBL-SCID mouse model of skin rejection. Transplantation. 1999;67(12):1590-9. PMID:10401767 
  189. Lymphoproliferative disease in children. Transplant Proc. 1999;31(1-2):1268-9. PMID:10083565 
  190. Paediatric inpatient morbidity patterns and drug usage in a teaching hospital serving an underdeveloped area. Indian J Public Health. 1999;43(2):64-6. PMID:11243068 
  191. Membranous glomerulonephritis and nephrosis post factor IX infusions in hemophilia B. Pediatr Nephrol. 1998;12(8):654-7. PMID:9811389 
  192. Acute interstitial nephritis presenting as presumed minimal change nephrotic syndrome. Pediatr Nephrol. 1998;12(7):576-8. PMID:9761358 
  193. Prevalence of microalbuminuria in children with sickle cell disease. Pediatr Nephrol. 1998;12(6):475-8. PMID:9745872 
  194. Unique aspects of chronic rejection in pediatric renal transplant recipients. Graft. 1998;1:S82-S88. 
  195. Ciprofloxacin overdose: acute renal failure with prominent apoptotic changes. Am J Kidney Dis. 1998;31(4):710-2. PMID:9531191 
  196. Immunosuppression of pediatric kidney transplant recipients: minimizing the risk of PTLD. Transplantation and Immunology Letters. 1998;14:3-12. 
  197. Effect of malnutrition and body size on renal size. Nephrology. 1998;4:361-365. 
  198. Central role for CD40/CD40 ligand (CD154) interactions in transplant rejection. Pediatr Transplant. 1998;2(1):6-15. PMID:10084754 
  199. Extra and central pontine myelinolysis in a child with adrenal insufficiency. Pediatr Neurol. 1997;17(2):158-60. PMID:9367298 
  200. Para/post infectious recovering encephalitis with localized basal ganglia involvement. Indian Pediatr. 1997;34(8):721-6. PMID:9492402 
  201. Sporadic Stiffman syndrome in a young girl. Pediatr Neurol. 1997;17(1):58-60. PMID:9308978 
  202. A child with cardiogenic shock and supraventricular tachycardia presenting in normal sinus rhythm. Pediatr Emerg Care. 1996;12(6):420-1. PMID:8989789 
  203. Use of banana leaves in Stevens-Johnson syndrome. Pediatr Dermatol. 1994;11(3):280-1. PMID:7971569 
  204. Primary hypokalemic periodic paralysis. Indian Pediatr. 1994;31(3):326-8. PMID:7896370 
  205. Acute renal failure in children requiring dialysis therapy. Indian Pediatr. 1994;31(3):305-9. PMID:7896366 
  206. Difficult to control epilepsy in childhood--a long term study of 123 cases. Indian Pediatr. 1993;30(10):1199-206. PMID:8077011 
  207. Albendazole. Indian Pediatr. 1993;30(9):1115-8. PMID:8125597 
  208. Prevalence of bacteriuria in febrile infants. Indian Pediatr. 1993;30(8):987-90. PMID:8125587 
  209. von Willebrand's disease with gastrointestinal telangiectasia. J Assoc Physicians India. 1993;41(6):395-6. PMID:8005986 
  210. Adverse drug reactions in pediatrics with a study of in-hospital intensive surveillance. Indian Pediatr. 1993;30(6):745-51. PMID:8132253